Code | 0512D | ||||||||||
MA number | EU/1/18/1324/002 | ||||||||||
Product Form: | plv iol 1x500 IU + 2,5 solv. (liek.inj.skl.+striek.inj.napl.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Bayer AG, Germany | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 22.11.2018 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 29.06.2023 |